Articles From: Canarc Appoints New CEO, Grants Stock Options, Announces Financing to Cancer Genetics, Inc. and Mayo Clinic Provide Update on Their Joint Venture to Develop Next Generation Sequencing Company Focused on Areas of Critical Need in Oncology


2014/1/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0921687001&sourceType=1 http://www.ccnmatthews.com/logos/20050705-canarc.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Canarc Appoints New CEO, Grants Stock Options, Announces Financing investment picks
2013/11/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0910634001&sourceType=1 http://www.ccnmatthews.com/logos/20050705-canarc.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Canarc Appoints New Director investment picks
2014/1/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0924978001&sourceType=1 http://www.ccnmatthews.com/logos/20050705-canarc.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Canarc Closes Fully Subscribed Private Placement Financing investment picks
2014/2/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0929214001&sourceType=1 http://www.ccnmatthews.com/logos/20050705-canarc.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Canarc Resource and Pan American Goldfields Sign Letter of Intent With Respect to a Business Combination and Announces CA$2.2 Million Private Placement Financing investment picks
2013/11/20
By Robb M.
Sign-up for Canberra Taps Former Bank Chief to Lead Financial Inquiry investment picks
Monday, September 30 Australia Family & Community Day (Canberra only) Banks, businesses and government offices close.
Sign-up for Canberra, Perth Banks Closed Monday -- Holiday Advisory investment picks
Cancellation of Stock Options Canada NewsWire TORONTO , Dec.
Sign-up for Cancellation of Stock Options investment picks
2013/12/12
Forrester Research, Inc. (Nasdaq: FORR) previously announced that Chief Financial Officer Michael A.
Sign-up for Cancellation: Forrester Research CFO To Speak At The Barclays Select Series 2013 - Information And IT Series Forum Conference investment picks
2014/4/11
More than 1,500 oncology professionals hear of pioneering radiosurgery treatments and knowledge-based planning techniques at two Varian-hosted symposia VIENNA , April 11, 2014 /PRNewswire/ -- Cancer experts have reported advances in radiosurgery treatments for the prostate, liver and spine, as well as significant developments in radiation oncology treatment planning using equipment and software from Varian Medical Systems (NYSE: VAR) .
Sign-up for Cancer Experts Detail Advances in Radiosurgery and Knowledge-Based Treatment Planning Using Varian Medical Systems Technologies investment picks
2013/9/3
Clinicians from the U.S., Europe, and Asia report promising results during medical meeting in Taiwan TAIPEI CITY, Taiwan , Sept.
Sign-up for Cancer Experts Detail New Approaches to Liver Cancer Treatment with Stereotactic Ablative Radiotherapy investment picks
RUTHERFORD, N.J., Oct.
Sign-up for Cancer Genetics Announces Closing of Public Offering of $46 Million of Shares of Common Stock investment picks
RUTHERFORD, N.J., Aug.
Sign-up for Cancer Genetics Announces Closing of Public Offering of 1,500,000 Shares of Common Stock investment picks
2014/3/5
93% Diagnostic Accuracy and 99% Specificity Support Implementation of the CGI Kidney Cancer Algorithm and Test in A Clinical Setting New Data Presented at USCAP Annual Meeting; 188 Patient Study Conducted in Conjunction with Cleveland Clinic RUTHERFORD, N.J. and SAN DIEGO, March 5, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI") announced today the results of a collaborative study conducted with The Cleveland Clinic to validate CGI's kidney cancer microarray test.
Sign-up for Cancer Genetics Announces Compelling Diagnostic Sensitivity (99%) and Accuracy (93%) for Its Patent-Protected Genomic Kidney Cancer Test investment picks
2013/9/5
RUTHERFORD, N.J., Sept.
Sign-up for Cancer Genetics Announces Exercise of Underwriters' Over-Allotment Option investment picks
2013/10/24
RUTHERFORD, N.J., Oct.
Sign-up for Cancer Genetics Announces Exercise of Underwriters' Over-Allotment Option investment picks
2014/4/4
New Test Launch Extends CGI's Leadership in Genomic Testing for Blood Cancers CALR Genetic Mutation Test Will Be A Part of CGI's Comprehensive Focus on Leukemia RUTHERFORD, N.J., April 4, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, has launched a genetic diagnostic test for detecting mutations in the calreticulin (CALR) gene.
Sign-up for Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms investment picks
RUTHERFORD, N.J., Aug.
Sign-up for Cancer Genetics Announces Pricing of Public Offering of 1,500,000 Shares of Common Stock investment picks
2013/10/22
RUTHERFORD, N.J., Oct.
Sign-up for Cancer Genetics Announces Pricing of Public Offering of 2,858,000 Shares of Common Stock investment picks
RUTHERFORD, N.J., Sept.
Sign-up for Cancer Genetics Announces Upcoming Investor Conference Schedule investment picks
2014/3/17
RUTHERFORD, N.J., March 17, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq:CGIX) , an emerging leader in DNA-based diagnostics, announced today that effective April 1, 2014, it has appointed Edward J.
Sign-up for Cancer Genetics Appoints Edward J. Sitar as Chief Financial Officer investment picks
2014/1/6
RUTHERFORD, N.J., Jan.
Sign-up for Cancer Genetics Appoints John Pappajohn Chairman of the Board of Directors investment picks
2014/4/10
Panna Sharma, CEO of Cancer Genetics, Is Moderating a Panel Entitled "Partnering for a Balanced Portfolio: Perspectives from Innovators, Partners, & Payers" RUTHERFORD, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, announced that the Company is a sponsor of the BioNJ International BioPartnering Conference where Panna Sharma will be moderating a panel on the topic of "Partnering for a Balanced Portfolio: Perspectives from Innovators, Partners, and Payers" today Thursday, April 10, 2014 at the Westin Princeton at Forrestal Village.
Sign-up for Cancer Genetics CEO Moderates Panel Discussion With Thought Leaders in Biopharma at the BioNJ 2014 International BioPartnering Conference investment picks
2014/4/3
RUTHERFORD, N.J., April 3, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) , an emerging leader in DNA-based diagnostics, announced today that a poster highlighting preliminary results of a study in clear cell Renal Cell Carcinoma (ccRCC) will be presented at the 105 th Annual Meeting of the American Association of Cancer Research ("AACR"), which will be held in San Diego, California April 5-9, 2014.
Sign-up for Cancer Genetics to Present New Data From Renal Cell Carcinoma Study at AACR investment picks
2014/2/10
RUTHERFORD, N.J., Feb.
Sign-up for Cancer Genetics to Provide Corporate Update at 16th Annual BIO CEO & Investor Conference in New York investment picks
2014/3/21
RUTHERFORD, N.J., March 21, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, announced today that it will report its results for the fourth quarter and year-end 2013 after the market close on Wednesday, March 26, 2014.
Sign-up for Cancer Genetics to Report Fourth Quarter and Year-End 2013 Results on Wednesday, March 26, 2014 investment picks
RUTHERFORD, N.J., Sept.
Sign-up for Cancer Genetics, Inc. (CGIX) Expands Relationship With Roche Servicios S.A. investment picks
2014/2/26
RUTHERFORD, N.J., Feb.
Sign-up for Cancer Genetics, Inc. Adds Additional Kidney Cancer Patent to its Portfolio investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Canarc Appoints New CEO, Grants Stock Options, Announces Financing to Cancer Genetics, Inc. and Mayo Clinic Provide Update on Their Joint Venture to Develop Next Generation Sequencing Company Focused on Areas of Critical Need in Oncology
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity